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thyroids following in vivo astatine-211 exposure
reveals distinct gene expression profiles
Nils Rudqvist1*, Toshima Z Parris2, Emil Schüler1, Khalil Helou2 and Eva Forssell-Aronsson1Abstract
Background: Astatine-211 (211At) is an alpha particle emitting halogen with almost optimal linear energy transfer
for creating DNA double-strand breaks and is thus proposed for radionuclide therapy when bound to tumor-
seeking agents. Unbound 211At accumulates in the thyroid gland, and the concept of basal radiation-induced
biological effects in the thyroid tissue is, to a high degree, unknown and is most valuable.
Methods: Female BALB/c nude mice were intravenously injected with 0.064 to 42 kBq of 211At, resulting in
absorbed doses of 0.05 to 32 Gy in the thyroid gland. Thyroids were removed 24 h after injection; total RNA was
extracted from pooled thyroids and processed in triplicate using Illumina MouseRef-8 Whole-Genome Expression
Beadchips.
Results: Thyroids exposed to 211At revealed distinctive gene expression profiles compared to non-irradiated
controls. A larger number of genes were affected at low absorbed doses (0.05 and 0.5 Gy) compared to
intermediate (1.4 Gy) and higher absorbed doses (11 and 32 Gy). The proportion of dose-specific genes increased
with decreased absorbed dose. Additionally, 1.4 Gy often exerted opposite regulation on gene expression
compared to the other absorbed doses. Using Gene Ontology data, an immunological effect was detected at 0.05
and 11 Gy. Effects on cellular response to external stress and cell cycle regulation and proliferation were detected at
1.4 and 11 Gy.
Conclusions: Conclusively, the cellular response to ionizing radiation is complex and differs with absorbed dose. The
response acquired at high absorbed doses cannot be extrapolated down to low absorbed doses or vice versa. We also
demonstrated that the thyroid - already at absorbed doses similar to those obtained in radionuclide therapy - responds
with expression of a high number of genes. Due to the increased heterogeneous irradiation at low absorbed doses, we
suggest that this response partly originates from non-irradiated cells in the tissue, i.e., bystander cells.
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Since the first measurement of clonogenic cell survival
of HeLa cells exposed to X-rays in 1955 [1] and up to
the early 1990s, radiobiological research has mainly
focused on cell death and survival with an approach from
the target-cell hypothesis. It was believed that the direct
killing of parenchymal and vascular endothelial cells suc-
cessively led to organ failure [2,3]. In addition, the time* Correspondence: nils.rudqvist@radfys.gu.se
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mal tissue effects was considered to be ‘silent’, without any
signs of tissue damage. For acute normal tissue damage,
the target-cell hypothesis is still viable; however, it is not
as reliable for modeling late normal tissue damage [4].
The discovery of early radiation-induced cytokine cas-
cades in 1995 was a major step towards new concepts in
radiobiology [5]. These findings, together with the identifi-
cation of the bystander effect and studies of late side
effects such as radiation-induced fibrosis, sequentially lead
to a paradigm shift where the basal mechanisms of the
cellular and molecular response to ionizing radiation nows an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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ionizing radiation may be seen as an orchestrated reaction
where cell loss and gene expression both play important
roles.
Astatine-211 (211At), an α-decaying radiohalogen, is con-
sidered to be an optimal therapeutic radionuclide with a
mean dose-average linear energy transfer of 98.8 keV/μm,
[7]. 211At-labeled tumor-seeking agents have been used in
trials on both animals and humans [8-11]. However, meta-
bolism of 211At-labeled substances involves release of 211At
and uptake in, e.g., the thyroid gland. It has been shown
that, while iodine is primarily transported into the thyroid
follicle cells through the sodium-iodide symporter (NIS),
astatine transport is less dependent on NIS [12].
The function of a cell is regulated by the expression of its
genes. The level of gene expression is regulated by signal
transduction pathways, which are biochemical signals that
may originate within and/or outside the cell. A snapshot of
cellular activity in response to external stimuli (e.g., ionizing
radiation) can be obtained by measuring gene expression at
the transcriptome level. In the present study, this is per-
formed using high-throughput microarray analysis.
Earlier studies of radiation-induced transcriptional
changes have mainly been performed in vitro in a con-
trolled environment [13,14]. Few in vivo studies have been
reported from animal experiments. Significant differences
in gene expression signatures were observed for X-ray-
exposed mouse brain, rectum, and kidney, varying between
the different tissue types and time after exposure [15].
The aim of this study was to investigate in vivo thyroi-
dal response in mice to 211At exposure by using gene
expression analysis to determine potential dose–
response relationships. Also, we wanted to validate genes
suggested as biomarkers for radiation damage.
Methods
Radionuclides and radioactive measurements
211At was produced at the Cyclotron and PET Unit at
Rigshospitalet in Copenhagen, Denmark, using the 209Bi
(α,2n)211At reaction, and free 211At was prepared as
described previously [16]. A gamma counter (Wallac
1480 WizardW 3", Wallac Oy, Turku, Finland) was used
to measure the activity in stock solutions and syringes
before and after injection.
Absorbed-dose calculations
The mean absorbed dose was calculated according to con-







where Ãthyroid is the cumulated activity in the thyroid
gland, ni is the yield of the radiation i with energy Ei, φi isthe absorbed fraction for radiation i in the target tissue,
and mthyroid is the mass of the thyroid [17].
The cumulated activity was calculated using previously
published biodistribution data, where percentage of
injected activity were given at t= 0, 1, 2, 4, 6, and 24 h
after injection for a number of organs [18]. Then, to
derive the cumulated activity, the trapezoidal rule was
used to interpolate between two consecutive time points.
Consequently, the relationship between cumulated activ-
ity and injected activity (IA) was determined to be
Ã= 2,100*IA. The absorbed fraction was set to 1 as the
mean range for alpha particles emitted from 211At is
about 65 μm, and a standard thyroid mass of 3 mg was
used (equal to roughly 3 μl) [19]. Furthermore, the
absorbed-dose calculations only included energy depos-
ited from alpha particles emitted from 211At and its
daughter nuclide 211Po located in the thyroid.
Animal experiment
Twenty-one female BALB/c nude mice aged 6 months
were divided into six groups and weighed. The mice in
five groups were intravenously injected in the tail vein
with 0.064, 0.64, 1.8, 14, and 42 kBq 211At diluted in
phosphate-buffered saline (pH 7). The sixth group was
used as controls and treated with an empty syringe. The
animals were killed after 24 h by cardiac puncture under
anesthesia with pentobarbitalnatrium. The thyroids were
collected, immediately snap-frozen in liquid nitrogen,
and stored at −80°C until analysis. The absorbed doses
delivered to the thyroids were 0.05, 0.5, 1.4, 11, and
32 Gy during 24 h.
Gene expression analysis
Thyroid tissue from animals in the same group was
pooled, and total RNA was extracted using the RNeasy
Lipid Tissue Mini Kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer's instructions. The RNA samples
were processed in triplicate at the Swegene Center for
Integrative Biology Genomics DNA Microarray Resource
Center (SCIBLU, Lund, Sweden) using MouseRef-8
Whole-Genome Expression Beadchips (Illumina, San
Diego, CA, USA). Images and raw signal intensities were
acquired using the Illumina BeadArray Reader scanner
and Illumina BeadScan 3.5.31.17122 (Illumina, San Diego,
CA, USA) image analysis software, respectively. Data pre-
processing and quantile normalization were applied to the
raw signal intensities using the web-based BioArray Soft-
ware Environment system provided by SCIBLU. Further
data processing was performed in Nexus Expression 2.0
(BioDiscovery, El Segundo, CA, USA) as previously
described [20]. Differentially expressed transcripts (≥1.5-
fold change) were identified with a Benjamini-Hochberg
adjusted p value cutoff of <0.01, while enriched Gene
Ontology (GO) terms associated with a gene set were
Rudqvist et al. EJNMMI Research 2012, 2:32 Page 3 of 12
http://www.ejnmmires.com/content/2/1/32identified using a p value cutoff of <0.05. The GO data
obtained from the Nexus software were further analyzed
and categorized using a web-based GO term search func-
tion [21,22]. Gene expression data discussed in this publi-
cation have been deposited at the NCBI's Gene Expression
Omnibus [GEO:GSE32306].
The Human Protein Atlas and UniGene were used to
establish normal expression of genes at the protein level
in human thyroid and transcriptional level in mouse
thyroid, respectively [23,24]. This analysis was only per-
formed for differentially expressed genes common to all
absorbed doses. In addition, the expression level of genes
reported in the literature as potential biomarkers for ret-
rospective dosimetry was investigated [13,14].Results and discussion
Results
General transcriptional changes
Distinct gene expression profiles were found in 211At-irra-
diated mouse thyroid tissue exposed to different absorbed
doses (0.05, 0.5, 1.4, 11, or 32 Gy), compared to non-
irradiated controls (Table 1 and Additional file 1). The
highest number of differentially expressed transcripts
(1,636 transcripts) was detected at 0.5 Gy, whereas the
lowest absorbed dose (0.05 Gy) had a slightly lower impact
on the transcriptome with 1,225 regulated transcripts. The
number of regulated transcripts for the higher absorbed
doses (1.4, 11, and 32 Gy) was 544, 575, and 425, respec-
tively. Furthermore, down-regulation was predominantly
observed at lower absorbed doses (0.05 and 0.5 Gy), and
up-regulation, at higher absorbed doses (11 and 32 Gy).
An intermediate phase was observed at 1.4 Gy, where an
almost equal number of suppressed and induced tran-





Number of up- and
down-regulated
transcripts
0.05 1,225 " 338
# 887
0.5 1,636 " 480
# 1,156
1.4 544 " 284
# 260
11 575 " 412
# 163
32 425 " 293
# 132
Total number of regulated (up- and down-regulated) transcripts in mouse
thyroid glands after exposure to 211At. Up arrow, up-regulated transcript;
down arrow, down-regulated transcript.A high proportion of transcripts affected after exposure
to 0.5 and 1.4 Gy were dose-specific (25% and 40%,
respectively), whereas less than 8% of the transcripts
detected at 0.05, 11, and 32 Gy were dose-specific (Figure 1
and Additional file 2). The high prevalence of down-
regulation at the lowest absorbed doses (0.05 and 0.5 Gy)
was common and unique for these treatment groups,
among which 37% and 50% of the transcripts were down-
regulated, respectively (Additional file 2).
Effects of 211At irradiation on biological processes
Significantly expressed transcripts were associated to biolo-
gical processes through gene ontology terms using the
Nexus software (Table 2 and Additional file 3). The number
of affected biological processes was highest at 1.4 Gy, with
27 affected processes. The affected biological processes
were classified into seven broad GO terms: (1) immune
response, (2) response to stimulus, (3) metabolism, (4)
developmental process, (5) transport, (6) cellular process,
and (7) system process (Table 2). Both 0.05 and 11 Gy
induced an immunological response by regulating a general
immune response (0.05 Gy), promoting thymic T cell selec-
tion (0.05 Gy), and by affecting B cell proliferation (11 Gy).
In particular, absorbed doses of 0.5, 11, and 1.4 Gy had an
impact on cellular response to stimulus, where 1.4 Gy
affected biological processes connected to response to
external stress. Exposure to 1.4 and 11 Gy also affected bio-
logical processes and signaling pathways involved in cell
cycle regulation and proliferation (1.4 Gy: small GTPase
signal transduction and transmembrane receptor protein
tyrosine kinase signaling pathway; 11 Gy: G protein signal-
ing and G protein receptor protein signaling pathway). An
effect on metabolism was observed in all irradiated groups;
however, 0.5 Gy affected both the highest number of
unique and nonunique metabolic processes. Compared to
0.05, 0.5, and 32 Gy, absorbed doses of 1.4 and 11 Gy had a
higher impact on developmental processes, e.g., differentia-
tion and bone mineralization. Effects on transport of inor-
ganic compounds were observed at all absorbed doses,
while transport of organic compounds was only detected
after exposure to 0.5 and 1.4 Gy.
Common differentially expressed transcripts among
irradiated groups
In total, 130 differentially expressed transcripts (117
genes) were common for all absorbed doses (Figure 2).
These play an important role in cellular metabolism,
transport and communication, DNA, RNA and protein
processing, immune response, apoptosis, cellular main-
tenance, and cell development. Of these, 40 transcripts
(38 genes) were consistently up-regulated, and 46 tran-
scripts (37 genes) were down-regulated in all groups.
Interestingly, 43 transcripts (41 genes) associated with
cellular transport, metabolism, and communication were
Figure 1 Proportion of shared genes at the different absorbed dose levels. The distribution of regulated transcripts is shown in a radar
plot for the different absorbed dose levels: (A) 0.05 Gy, (B) 0.5 Gy, (C) 1.4 Gy, (D) 11 Gy, and (E) 32 Gy. For example, in (A), 91%, 18%, 36%, and
29% of the transcripts regulated at 0.05 Gy were also regulated at 0.5, 1.4, 11, and 32 Gy. For the exact distribution of regulated transcripts,
see Additional file 2.
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groups. In addition, 12 transcripts representing nine
genes associated with proteolysis (Egfbp2, Klk1b11,
Klk1b16, Klk1b21, Klk1b22, Klk1b27, Klk1b4, Klk1b5,
and Klk1b9) were present in highly elevated levels for
0.05, 0.5, 11, and 32 Gy (comparison log2 ratio, 3.6 to
6.6) but expressed to a lower extent for 1.4 Gy (compari-
son log2 ratio, 0.6 to 2.8).
Among the 130 shared transcripts, 12/34 transcripts nor-
mally expressed in mouse thyroids and 31/96 transcriptsfor which gene expression has not yet been determined in
normal mouse thyroid were down-regulated after exposure
to 1.4 Gy but up-regulated after exposure to 0.05, 0.5, 11,
and 32 Gy (Figure 2). Furthermore, 18/31 transcripts with
protein expression, 5/16 transcripts with no protein
expression, and 20/83 transcripts having unknown protein
expression in normal human thyroid tissue were up-
regulated at the RNA level in mouse thyroids after expo-
sure to 1.4 Gy, but down-regulated at the other four
absorbed doses.
Table 2 Affected biological processes (GO terms)
categorized after function
Biological process Absorbed dose (Gy)
0.05 0.5 1.4 11 32
Cellular process 4 1 1 2 2
Collagen fibril organization ✓
Cytolysis ✓
Epithelial cell differentiation ✓
Mitochondrion organization and biogenesis ✓
Negative regulation of endothelial cell
proliferation
✓
Cytoskeleton organization and biogenesis ✓ ✓ ✓
Cell migration ✓
Negative regulation of microtubule
depolymerization
✓
Immune response 2 0 0 1 0
Positive regulation of immune response ✓
Positive thymic T cell selection ✓
B cell proliferation ✓
Metabolic process 7 13 7 5 4
Protein amino acid glycosylation ✓
Regulation of metabolism ✓





Tricarboxylic acid cycle ✓ ✓
Ubiquinone biosynthesis ✓ ✓
Cellular protein metabolism ✓
Cholesterol biosynthesis ✓
Electron transport ✓




Acetyl-CoA biosynthesis from pyruvate ✓
Amino acid biosynthesis ✓
Retinoid metabolism ✓
Signal peptide processing ✓
tRNA processing ✓
Peptidoglycan metabolism ✓
Thyroid hormone generation ✓ ✓
One-carbon compound metabolism ✓ ✓
Cholesterol metabolism ✓
Steroid metabolism ✓
Phosphocreatine metabolism ✓ ✓
Lipopolysaccharide biosynthesis ✓ ✓
Carbohydrate metabolism ✓
Table 2 Affected biological processes (GO terms)
categorized after function (Continued)
Transport 3 5 6 3 3
Oxygen transport ✓
Secretion ✓ ✓
Potassium ion transport ✓ ✓ ✓ ✓ ✓
Protein transport ✓
Transport ✓ ✓
Ion transport ✓ ✓ ✓ ✓
Glucose transport ✓
Iron ion transport ✓
Vesicle-mediated transport ✓
Diuresis ✓
Sodium ion transport ✓
Response to stimulus 0 1 5 2 0
Response to unfolded protein ✓
Chemotaxis ✓
Response to cold ✓
Response to hypoxia ✓
Small GTPase signal transduction ✓
Transmembrane receptor protein tyrosine
kinase SP
✓
G protein signaling ✓
G protein receptor protein signaling
pathway
✓
System process 2 2 2 3 2
Muscle contraction ✓ ✓ ✓ ✓
Regulation of muscle contraction ✓ ✓ ✓ ✓ ✓
Vasoconstriction ✓
Digestion ✓
Developmental process 2 1 4 5 2
Vasculogenesis ✓





Regulation of bone mineralization ✓
Cartilage condensation ✓ ✓
Bone mineralization ✓
Brown fat cell differentiation ✓
Male gonad development ✓
Mechanoreceptor differentiation ✓ ✓
Muscle development ✓
Transcripts with different gene expression levels are connected to biological
processes (p< 0.05) through Gene Ontology terms. The main terms (cellular
process, immune response, metabolic process, transport, response to stimulus,
system process, and developmental process) have been compiled using the
Gene Ontology search function [21,22]. Numbers presented after the main
terms represent the number of affected biological processes for each
absorbed-dose profile.
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Figure 2 Differentially expressed genes present at all absorbed
doses. Genes categorized by known gene expression in mouse
thyroid according to UniGene and The Human Protein Atlas. Second
column: genes are listed together with their log2 ratio value where
the red color scale and the green color scale represent the
magnitude of gene down-regulation and up-regulation, respectively.
Genes annotated with ‘Unknown’ are genes with unknown gene
and/or protein expression in normal thyroid tissue, and genes
annotated with ‘o’ indicate that the gene is not expressed in normal
thyroid tissue. For gene expression in mouse thyroid tissue, ‘+’
indicates gene expression, whereas for protein expression, ‘+’, ‘++’,
or ‘+++’ indicates weak, moderate, or strong protein expression
levels, respectively. The fifth column shows the log2 values of gene
expression in non-irradiated mouse thyroids (the present study).
Genes with a value equal to or greater than log2 6.8 are considered
as expressed in normal mouse thyroid.
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at the RNA level at all absorbed doses and have, according
to UniGene and The Human Protein Atlas, unknown gene
expression and no protein expression in normal mouse
and human thyroid tissue, respectively. In addition, the
Ttr (carrier of the thyroid hormone thyroxine) and Crisp1
genes, normally expressed in human thyroid tissue, were
down-regulated at all absorbed doses compared to non-
irradiated controls.
To determine the number of normally expressed tran-
scripts in mice thyroid, the expression levels in non-
irradiated mice were investigated. The expression levels
of genes with known mRNA expression in the thyroid
ranged from log2 value 6.8 to 13.8 in non-irradiated con-
trols (Figure 2). Among the shared genes with unknown
expression at the mRNA level in mice thyroid tissue, all
but one (Klk1b21) had a value higher than 6.8. Further-
more, 13,975 (10,578 genes) of the total number of
25,683 probes represented on the Illumina Beadchip had
a log2 value higher than 6.8 (Additional file 4).
The dose–response relationship for the expression level
of the 130 shared transcripts exhibited different patterns
(Figure 3). The expression levels of Amy2-2, Prb1, Abpb,
and Muc10 were clearly dose independent. The Rab15,
Csprs, and Unc13b genes were suppressed for 1.4 Gy and
up-regulated for 0.05, 0.5, 11, and 32 Gy, while Klk1b21,
Klk1b4, and Smgc were more over-expressed for 0.05, 0.5,
11, and 32 Gy compared to 1.4 Gy. The Chia and Dnase1
genes involved in apoptosis and immune response were
highly suppressed at all absorbed doses but less sup-
pressed at 11 Gy. The Rpl3l, Cox6af, and Mylpf genes had
a u-shaped gene expression profile with high up-
regulation for 0.05 and 32 Gy, less up-regulation for 0.5
and 11 Gy, and the least up-regulation for 1.4 Gy. The Irs2
gene displayed two levels of gene expression: slight
increase in gene expression for lower absorbed doses (0.05
and 0.5 Gy) and higher increase in gene expression for
higher absorbed doses (1.4, 11, and 32 Gy).
Figure 3 Gene expression patterns for a selection of genes vs. absorbed dose. A selection of genes chosen in order to illustrate the
different gene expression patterns among the 130 differentially expressed genes at all absorbed doses studied. Values for gene expression are
given as comparison log2 ratio values related to non-irradiated tissue.
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Genes associated with ion transport were differentially
expressed throughout the material. The Solute carrier
family 5 member 8 (Slc5a8) gene, which is involved in
controlling transmembrane iodine transport, was sup-
pressed in thyroids irradiated with 1.4 Gy but present at
elevated levels in all other groups. Several other genes
belonging to the solute carrier family were also differen-
tially expressed (Additional file 1).
The Ttr and Urah (synonym: 1190003j15rik) genes, both
associated with thyroid hormone transport, were differen-
tially expressed after irradiation at all absorbed doses, and
at all absorbed doses except 32 Gy, respectively. While Ttr
was consistently down-regulated, Urah was down-regulated
at 1.4 Gy and up-regulated at 0.05, 0.5, and 11 Gy.
Comparison with previously known radiation-associated
genes
Few radiation-specific genes from the literature were dif-
ferentially expressed in mouse thyroids 24 h following
injection of 211At (Table 3) [13,14]. The Amy1 and Amy2
genes, which have unknown functions in the thyroid,
were both substantially suppressed at all absorbed doses
compared to non-irradiated controls. The Ccnd1 and
Gjb2 genes were expressed in the opposite direction at
1.4 Gy when compared with 0.5 Gy and 0.05, 0.5 and
11 Gy, respectively. Several genes associated with the
tumor necrosis factor superfamily (Tnfaip8, Tnfrsf19, and
Tnfrsf21) were slightly up-regulated at various absorbed
doses. The Trp53inp1 gene was up-regulated at 0.05, 1.4,
11, and 32 Gy, while Trp53inp2 was down-regulated at0.5 Gy. Both genes are associated with response to
double-strand DNA breaks and apoptosis induction.Discussion
The present study represents a multifaceted and extensive
approach to investigate the transcriptional changes in nor-
mal mouse thyroid tissue after internal exposure to 211At.
A broad range of absorbed doses were used, from 0.05 to
32 Gy delivered over 24 h, in order to make the study valid
for both environmental and clinical practices.
The results show that the mouse thyroid gland responds
to radiation in an absorbed-dose-dependent manner but
with few common differentially expressed genes and
affected biological functions at all absorbed doses studied.
The most surprising results were the wide biological
response involving a large set of genes differentially
expressed between different absorbed doses and that few of
the genes currently known to be associated with cellular
radiation damage were differentially expressed, which
implies an organ-specific response to ionizing radiation.
Exposure to 211At resulted in a strong transcriptional
response in mouse thyroid tissue, with the most substan-
tial impact on the transcriptome at the two lowest
absorbed doses studied (0.05 and 0.5 Gy). To the best of
our knowledge, no studies to date (in vivo, ex vivo, or
in vitro) have compared the number and the type of dif-
ferentially expressed transcripts over such a wide
absorbed-dose range. This makes it difficult to compare
and validate the distribution and specificity of the differ-
entially expressed transcripts identified in this study.




0.05 Gy 0.5 Gy 1.4 Gy 11 Gy 32 Gy
Amy1 (Mycbp) −4.6 −4.8 −3.6 −3.0 −4.5









































Table 3 Radiation-associated genes (Continued)
Tnfaip8 0.7
Tnfrsf10b
Tnfrsf19 0.7 0.6 0.7
Tnfrsf21 0.7 1.0 0.9 0.6
Tp53









Genes associated with radiation-induced biological response according to
Snyder and Morgan [13] and Chaudhry [14]. Values for gene expression are
given as comparison log2 ratio values. Note that the Illumina MouseRef-8
Beadchip is a whole-genome expression assay; however, some gaps in the
genome do exist, and several genes are represented under other aliases.
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able foundation for future studies similar to this one.
Few differentially expressed genes were common for the
different absorbed doses. Similarities were mainly observed
when comparing 0.05 with 0.5 Gy. From the distribution of
differentially expressed transcripts, it is evident that, at low
absorbed doses where a similar transcriptional response
was anticipated, the response shifts (the number and direc-
tion of regulated genes) as the absorbed dose increases
from 0.5 to 1.4 Gy. In addition, although 1.4 Gy had the
highest proportion of non-shared transcripts compared
with the other absorbed doses, the pooled response at 0.05
and 0.5 Gy was even more unique. Together, these findings
indicate that there is an underlying fundamental difference
in the cellular response to radiation after low-dose irradia-
tion compared to high doses with an intermediate phase at
1.4 Gy.
Gene ontology data provide comprehensive descriptions
of defined gene product properties, which describe how
genes function in a normal cellular context. The Nexus
software is quite specific and does not classify regulated
biological functions into main categories. However, a
broader categorization was performed using a web-based
GO term search function [21,22]. In the present investiga-
tion, the regulated biological functions were classified
under seven different main biological processes (cellular
process, immune response, metabolic process, transport,
response to stimulus, system process, and developmental
process). Biological processes related to cell signaling and
response to stimuli with an impact on cell cycle regulation
and proliferation were activated through the signal trans-
duction pathway and only detected at 1.4 and 11 Gy.
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absorbed doses with a peak at 1.4 Gy. Together with regu-
lation of signal transduction at 1.4 Gy, this indicates that
there is a high activity of activated cellular processes in the
thyroid. We suggest that this is a radiation-induced
response to damages in the DNA and/or other sub-cellular
components from absorbed doses high enough to produce
a severe but still reparable damage. At absorbed doses
above 11 Gy, lesions are probably too large to be repaired,
resulting in reduced cellular activity to primarily maintain
survival since some transport and signal transduction sys-
tems are still working to some extent. Immune response
was observed in thyroid tissue after exposure to 0.05 and
11 Gy. However, no biological processes related to inflam-
matory response were detected at any absorbed doses.
These results are in agreement with a previous study on
gene expression levels in mouse brain and kidney tissue
where an inflammatory response was not triggered 8 and
24 h after irradiation [15]. Inflammation is a primary acute
response to radiation damage with regulation of chemo-
kines and cytokines minutes to hours subsequent irradia-
tion; after which, a more proliferative phase begins with
cell migration and macrophage and monocyte activity [2].
Since the present study has been performed with internal
ongoing irradiation with maximum uptake of 211At at 16 h
after injection, killing the animals 24 h following irradiation
might be too late a time point to observe regulation of che-
mokines and cytokines and too early for late inflammatory
effects. To further study the inflammatory response at a
transcriptional level, studies with different temporal end
points are needed. In addition, metabolic, system, and
developmental processes are regulated at all absorbed
doses. We suggest that these are related to basal cellular
maintenance functions.
Radiation damage will eventually be healed through
tissue remodeling, and an excessive deposition of col-
lagen is a known characteristic of radiation fibrosis. Col-
lagen synthesis usually occurs months to years after
radiation damage; hence, effects related to collagen were
not likely to be apparent in the present study [2]. How-
ever, an effect on collagen fibril organization was
observed after exposure to 0.05 Gy, indicating fibrogen-
esis activity. In addition, up-regulation of the pro-
inflammatory tumor necrosis factor alpha (Tnfa) is an
early sign of radiation-induced fibrogenesis [25]. Activa-
tion of Tnfaip8 was observed at 1.4 Gy alone, but genes
associated with tumor necrosis factor receptors were up-
regulated at all absorbed doses except for 1.4 Gy.
Statistically, a mean absorbed dose of 1.2 Gy results in
one alpha particle track per thyroid cell, which is close
to the 1.4 Gy used in this study. Consequently, 0.05 and
0.5 Gy will result in hitting only approximately 4% and
40% of the cells in the thyroid gland (A Josefsson and E
Forssell-Aronsson, unpublished work). The increase inabsorbed dose from 0.05 and 0.5 Gy to 1.4 Gy should,
therefore, not mainly result in an increase of energy
deposited in each cell but rather in an increased number
of cells hit. If this is true, the biological effects reflected
by the gene expression seen at 0.05 and 0.5 Gy would be
diluted (the same transcripts affected, but with lower
magnitude) as the majority of the cells participating in
the analysis are not actually irradiated (but still included
in the analysis). In addition, at 0.05 and 0.5 Gy, the com-
plete thyroidal response involves a much higher number
of genes compared to when a higher proportion of cells
are irradiated. These results could be explained by a
bystander effect, with regulation (activation and/or
repression) of a substantial number of genes at lower
absorbed doses with origin in non-irradiated cells. Gene
expression studies of the bystander effect in vitro have
shown that non-irradiated cells exposed medium from
irradiated cells primarily induced over-expression of a
large number of genes [26]. This is not consistent with
our data as the majority of genes detected only at 0.05
and 0.5 Gy were primarily down-regulated. Another
study used a low fluency of alpha particles and demon-
strated that, when only 2% of the cell population was
irradiated, the CDKN1A, CDC2, CCNB1, and RAD51
genes were expressed in a greater proportion of cells
than anticipated, an effect that decreased in the presence
of a gap junction inhibitor [27]. None of these genes
were affected in the present study with the exception of
Cdkn1a, which was down-regulated after exposure to
0.5 Gy. The lack of response in these genes may be
related to the timing of the experiment.
As a result of working with an animal model, the
injected 211At will circulate throughout the body and,
thus, irradiate organs other than the thyroid. As a conse-
quence of organ interaction (through, e.g., signaling and
hormones), some of the biological response seen in the
present study may originate from tissues other than the
thyroid. A previous study using 131I demonstrated that
very low absorbed doses (in milligray level) had a dis-
tinct impact on gene expression in the liver, spleen, kid-
neys, and lung 24 h after injection [28]. Assuming that
this also occurs after 211At exposure, signaling sub-
stances emitted from other organs in the mouse might
have an impact on gene expression in the thyroid.
To fully understand the cellular response to ionizing
radiation, it is necessary to have a comprehensive picture
of the normal expression of genes and different signaling
pathways involved in each specific tissue. Therefore, we
identified normally expressed genes in normal mouse
thyroid tissue by comparing mRNA expression levels for
transcripts with previously known and unknown expres-
sion patterns in mouse thyroid [29]. However, compared
to expression in normal thyroid tissue, genes down-
regulated in irradiated thyroid tissue must have some
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untreated thyroid tissue. The shared genes with known
expression at the mRNA level in normal mouse thyroid
tissue had a log2 value between 6.8 and 13.8 in non-
irradiated mouse thyroid tissue. We used the lower log2
value as a cutoff where all genes with a log2 value over
6.8 were considered as normally expressed. All but one
of the genes (Klk1b21) that were differentially expressed
at all absorbed doses were expressed in normal mouse
thyroid. By using this method, we identified 10,578 tran-
scripts in the present study with elevated mRNA levels.
Thyroid stunning is a debated phenomenon where a low
amount of radioiodine administered for treatment planning
results in a lower thyroid uptake of administered radioio-
dine at the subsequent treatment [30]. The gene SLC5A5
encodes for the sodium-iodide symporter, which is respon-
sible for transporting iodine and, to some extent, astatine
into the thyroid follicles [12]. Transport of iodine after
211At exposure has been measured in an in vitro system
using thyroid cells where an increase in iodine transport
was reported immediately after irradiation ended. At 12 h,
the iodine transport returned to normal only to further
decrease over the following 5 days. Down-regulation at the
mRNA level of NIS was 61% at 5 days after irradiation
compared with non-irradiated controls [31]. In humans,
the SLC5A8 gene encodes for the sodium/monocarboxy-
late transporter, which is 70% homologous to NIS [32]. In
the present study, the Slc5a8 gene was down-regulated at
1.4 Gy, but up-regulated at all other absorbed doses. Sev-
eral other genes that belong to the solute carrier group
were also differentially expressed, but their impact on
iodide transport is still unknown. Additionally, the Ttr gene
(down-regulated for 1.4 and 11 Gy) encodes for the trans-
thyretin protein, which takes part in transporting thyroxine
(T4). Little is known about the expression of transthyretin
in human thyroid tissue, and it is mainly produced in the
brain and liver. Taken together, the thyroid function is
affected at some level; however, the impact it may have at a
higher translational level is unclear. In addition, we suggest
that future studies should include measurements of the
thyroid stimulating hormone blood levels as well as other
suitable biomarkers of thyroid function.
The 130 transcripts differentially expressed and shared
among all irradiated groups may be attributed to (1)
genes with normal expression in thyroid tissue, (2) genes
not normally expressed but still specific for thyroid tis-
sue, and (3) genes that are specific for 211At irradiation.
However, as majority of these transcripts have unknown
protein expression in human thyroid tissue (83/130) and
unknown gene expression in mouse thyroid tissue (96/
130) (according to The Human Protein Atlas and Uni-
Gene, respectively), the possibility to determine this dis-
tribution is limited. Furthermore, not corresponding
with UniGene and The Human Protein Atlas, Dmbt1(synonym: Crp) and Rab27a are expressed at the mRNA
level in mouse thyroid and at the protein level in human
thyroid, respectively [33,34]. In addition, Dnase1 has
detectable mRNA levels in mouse thyroid [29]. Also,
several highly affected genes detected in the present
study have unknown biological functions, such as Spt1
(up-regulated with fold change: 152, 152, 83, 143, and
123 at 0.05, 0.5, 1.4, 11, and 32 Gy, respectively) and
Smr1 (down-regulated with fold change: 115, 132, 138,
24, and 128 at 0.05, 0.5, 1.4, 11, and 32 Gy, respectively).
These genes may play an important role in the biological
response to irradiation, and further studies at the protein
level will possibly clarify their involvements.
In a clinical phase-I study, patients were infused with
211At-labeled monoclonal antibody fragments (absorbed
doses were 0.2 to 0.82 Gy and 0.02 to 0.18 Gy to the
unblocked and blocked thyroid, respectively) without
detecting any toxicological effects after 23 months [10].
These absorbed doses are close to the 0.05- and 0.5-Gy
doses used in the present study. Many cellular processes
and a high number of transcripts were regulated after
exposure at these low absorbed doses. We deem it
important to perform molecular studies on radiation-
induced changes in the thyroid at different temporal end
points in order to gain a more in-depth understanding
of possible damaging effects.
Gene expression profiling has been proposed as a poten-
tial biomarker for retrospective biodosimetry, and studies
have been performed primarily in vitro and ex vivo using
X-rays or gamma radiation [13,14]. The present study does
not validate the genes suggested as candidate biomarkers in
these reviews since a minor proportion were differentially
expressed in our data (Table 3). However, there are many
differences between internal alpha particle irradiation from
radionuclides and external irradiation, where a linear accel-
erator or gamma-emitting radionuclides are used. Addi-
tionally, in vitro and ex vivo studies do not provide a
comprehensive explanation of the causal effects of radiation
in tissues as these methods lack the complexity of a com-
plete organism with interacting tissues. Thyroid tissue con-
sists of many different cell types, both tissue-specific
(thyrocytes and C cells) and general cells (e.g., endothelial,
muscular, and fat cells). It is not likely that a single gene will
be able to function as a retrospective biomarker for biodosi-
metry; however, computational informatics have been used
to construct a 74 multi-genetic signature that can be used
to distinguish between four different absorbed doses (0.5, 2,
5, and 8 Gy using Cs-137 as a gamma source), an approach
which this present study supports [35].
Conclusions
In conclusion, these results demonstrate the complexity
of radiation-induced biological effects. Thus, care should
be taken when interpolating effects between high and
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level. We conclude that the thyroid was significantly
affected at absorbed-dose levels similar to those obtained
in radionuclide therapy for tumors. Due to the increased
heterogeneous irradiation at low absorbed doses, we
suggest that this response partly originates from non-
irradiated cells in the tissue, i.e., bystander cells.
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